Clinical trials
Phase 2 Heart Failure trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Terminated | 4 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| AstraZeneca | 3 |
| Cytokinetics | 3 |
| Bayer | 2 |
| Bristol-Myers Squibb | 1 |
| Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies | 1 |
| National Medical Research Center for Cardiology, Ministry of Health of Russian Federation | 1 |
| Population Health Research Institute | 1 |
| Relypsa, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 17 |
| Hyperkalemia | 2 |
| Renal Insufficiency, Chronic | 2 |
| Angina Pectoris | 1 |
| Breast Neoplasms | 1 |
| Cardiovascular Diseases | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Diabetic Nephropathies | 1 |
| Dyspnea | 1 |
| Essential Hypertension | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.